
The positive trajectory of epigenetic and sequencing innovations is set to enhance diagnostic capabilities across clinical and forensic settings as funding and infrastructure development advance. Notably, noninvasive biomarkers, including DNA methylation analyses, are gaining traction for early disease detection and patient-specific treatment adjustments, signaling a pivotal shift toward precision medicine. Continued surveillance will ensure responsiveness to any emerging contradictory data, underlining a low-risk posture for ongoing advancements.

Title not available for this citation.
“Differentially methylated regions were associated with miR-375 expression in HNSCC. Specially, hypermethylation in N shore region was independently associated with poor OS and DFS.”

Title not available for this citation.
“Emerging blood-based biomarkers such as cytolethal distending toxin B and antivinculin antibodies show promise in distinguishing IBS, and its bowel habit subtypes, from other gastrointestinal disorders with overlapping symptoms.”

Title not available for this citation.
“Additionally, stool-based biomarkers and breath tests may also predict response to interventions, like the low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet, and rifaximin.”

Title not available for this citation.
“Using cross-sectional data, relationship status (married/divorced/widowed) was expected to predict differences in DNAm between married persons and persons who experienced social loss (divorced/widowhood).”

Title not available for this citation.
“Without considering moderators, there was only one differentially methylated position (DMP; cg01450896), comparing married and widowed persons (b = 0.098, q = 0.022; Δ-beta = |0.015|)”

Title not available for this citation.
“Its use became widespread in Argentina during the socioeconomic crisis of 2001-2002 and is more prevalent among individuals under 25 and those from low socioeconomic backgrounds.”